Announcements
- ALK opjusterer forventningerne til omsætning og indtjening i 2024
- ALK upgrades its full-year revenue and earnings outlook
- ALK provides update on regulatory process for the house dust mite allergy tablet in China
- ALK giver opdatering på registreringsprocessen for tabletten mod husstøvmideallergi i Kina
- ALK launches new growth strategy and 2028 financial ambitions
- ALK lancerer ny vækststrategi og finansielle ambitioner for 2028
- ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
- ALK’s European registration application for ITULAZAX® for paediatric indication accepted for review
- Listen in on ALK’s Capital Markets Day on 4 June 2024
- Three-month interim report (Q1) 2024 (unaudited) - English version only
More ▼
Key statistics
On Thursday, ALK-Abello A/S (4AJ0:DUS) closed at 19.99, -6.24% below its 52-week high of 21.32, set on Jun 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.08 |
---|---|
High | 20.38 |
Low | 19.99 |
Bid | 19.93 |
Offer | 20.26 |
Previous close | 20.28 |
Average volume | 194.89 |
---|---|
Shares outstanding | 202.57m |
Free float | 112.81m |
P/E (TTM) | 61.31 |
Market cap | 30.95bn DKK |
EPS (TTM) | 2.49 DKK |
Data delayed at least 15 minutes, as of Jul 25 2024 18:31 BST.
More ▼